Current view and outcome of ITI therapy - A change over time?


HOLSTEIN K., BATOROVA A., CARVALHO M., FIJNVANDRAAT K., HOLME P., Kavakli K. , ...Daha Fazla

THROMBOSIS RESEARCH, cilt.148, ss.38-44, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Introduction: Inhibitor development in people with haemophilia is a serious complication that may require intensive and costly interventions. The goal of inhibitor management should be permanent inhibitor eradication through immune tolerance induction (ITI), but well-designed studies are lacking and the management of patients is therefore defined by the experience and views of the clinician.